HYDROCHLOROTHIAZIDE; PINDOLOL - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrochlorothiazide; pindolol and what is the scope of freedom to operate?
Hydrochlorothiazide; pindolol
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for HYDROCHLOROTHIAZIDE; PINDOLOL
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Clinical Trials: | 1 |
| Patent Applications: | 2 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE; PINDOLOL at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE; PINDOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| US Department of Veterans Affairs | |
| VA Office of Research and Development |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE; PINDOLOL
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; PINDOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | VISKAZIDE | hydrochlorothiazide; pindolol | TABLET;ORAL | 018872-002 | Jul 22, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | VISKAZIDE | hydrochlorothiazide; pindolol | TABLET;ORAL | 018872-001 | Jul 22, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
